These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 5597177)

  • 1. [A plan for hemodialysis in the treatment of patients with terminal, chronic nephropathy].
    Steiness I; Grysbjerg J
    Ugeskr Laeger; 1967 Jan; 129(3):73-7. PubMed ID: 5597177
    [No Abstract]   [Full Text] [Related]  

  • 2. [The treatment of chronic hyperazotemic nephropathies with periodic hemodialysis].
    Galanti G
    Minerva Med; 1967 Dec; 58(97):4323-5. PubMed ID: 6082385
    [No Abstract]   [Full Text] [Related]  

  • 3. [Management of phosphate in chronic kidney disease--Phosphorus control by hemodialysis with long treatment time].
    Tanaka M
    Clin Calcium; 2009 Feb; 19(2):194-7. PubMed ID: 19182358
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Future directions in therapy for chronic kidney disease].
    de Francisco AL
    Nefrologia; 2010; 30(1):1-9. PubMed ID: 20098467
    [No Abstract]   [Full Text] [Related]  

  • 5. New options to improve hemodialysis patient outcomes.
    Kliger AS
    Clin J Am Soc Nephrol; 2009 Apr; 4(4):694-5. PubMed ID: 19339421
    [No Abstract]   [Full Text] [Related]  

  • 6. Lipid management in chronic kidney disease, hemodialysis, and transplantation.
    Montague T; Murphy B
    Endocrinol Metab Clin North Am; 2009 Mar; 38(1):223-34. PubMed ID: 19217521
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chronic kidney disease 5 on hemodialysis in Nepal Medical College Teaching Hospital.
    Chhetri PK; Manandhar DN; Bhattarai SP; Pahari LR; Shrestha R
    Nepal Med Coll J; 2008 Mar; 10(1):8-10. PubMed ID: 18700622
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Ambulatory hemodialysis treatment of terminal chronic nephropathy].
    Berthelsen HC; Giese J; Nielsen VK; Thaysen JH
    Ugeskr Laeger; 1966 Aug; 128(31):885-96. PubMed ID: 5968808
    [No Abstract]   [Full Text] [Related]  

  • 9. Residual renal function and dialysis modality: is it really beneficial to preserve residual renal function in dialysis patients?
    Canaud B; Chenine L; Leray-Moragués H; Wiesen H; Tetta C
    Nephrology (Carlton); 2006 Aug; 11(4):292-6. PubMed ID: 16889567
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Nephrological care in Wielkopolska-region of Poland in 2009--realization of the united idea].
    Czekalski S
    Pol Merkur Lekarski; 2009 Jul; 27(157):5-9. PubMed ID: 19650420
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Patients in pre-dialysis: decision taking and free choice of treatment].
    Sarrias Lorenz X; Bardón Otero E; Vila Paz ML
    Nefrologia; 2008; 28 Suppl 3():119-22. PubMed ID: 19018749
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Determination of the effectiveness of plasma exchange in kidney diseases by a biological test].
    Nenov K; Kovachev D; Kovacheva P; Nenov D
    Vutr Boles; 1987; 26(4):54-8. PubMed ID: 3673035
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Antihypertensive therapy in patients with 4 and 5 stage chronic kidney disease undergoing periodic dialysis].
    Goicoechea MA
    Nefrologia; 2004; 24 Suppl(6):161-71, 187-235. PubMed ID: 15696905
    [No Abstract]   [Full Text] [Related]  

  • 14. [Cardiovascular disease in patients with 4 and 5 stage chronic kidney disease. Patient in chronic dialysis].
    Goicoechea MA
    Nefrologia; 2004; 24 Suppl(6):142-60, 187-235. PubMed ID: 15696904
    [No Abstract]   [Full Text] [Related]  

  • 15. The latest advances in kidney diseases and related disorders.
    Cases A
    Drug News Perspect; 2007 May; 20(4):271-8. PubMed ID: 17637941
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Further observations on the ophthalmoscopic picture during chronic renal insufficiency treated with periodic hemodialysis].
    Calogero R; Revoltella R; Ancona G; Bruschi E; Galanti G; Dalla Rosa C; Confortini P
    Minerva Med; 1967 Jun; 58(45):2110-3. PubMed ID: 6028370
    [No Abstract]   [Full Text] [Related]  

  • 17. [The importance of education in the management of chronic kidney disease patient].
    Martin PY; Droulez MG; Sexton-Dobby A; Marangon N; Hadaya K; Saudan P; Lacroix M; Stoermann-Chopard C; Bourquin V; Gombert-Jupille B
    Rev Med Suisse; 2009 Feb; 5(192):470-2, 474. PubMed ID: 19317314
    [TBL] [Abstract][Full Text] [Related]  

  • 18. How should chronic medical therapies be altered with the onset of end-stage renal disease and initiation of dialysis?
    Wyne KL; Fishbane S; Block GA; Warburton K; Berns JS; Neu AM; Warady BA
    Semin Dial; 2006; 19(1):8-24. PubMed ID: 16423174
    [No Abstract]   [Full Text] [Related]  

  • 19. Circulating type VI collagen and undulin, in patients with kidney diseases, after kidney transplantation and on hemodialysis.
    Marder K; Keller F; Schuppan D
    Clin Nephrol; 1995 Sep; 44(3):178-84. PubMed ID: 8556834
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Psychological characteristics and quality of life of patients with chronic kidney diseases].
    Petrova NN; Savvina NN; Vasil'eva IA
    Ter Arkh; 2003; 75(6):31-7. PubMed ID: 12920956
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.